Top

Published in:

01-04-2009 | CLINICAL CORRESPONDENCE

Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy

Authors: Univ. Prof. DDr. Josef Finsterer, MD, PhD, Claudia Stöllberger, MD

Published in: Clinical Research in Cardiology | Issue 4/2009

Excerpt

Sirs: Restrictive cardiomyopathy (rCMP) is echocardiographically characterized by bilaterally enlarged atria, a restrictive filling pattern (deceleration time <150 ms) but normal systolic function [20]. Although rCMP has been repeatedly reported as a cardiac manifestation of various neuromuscular disorders (NMDs), the association of pioglitazone-induced heart failure in a patient with rCMP due to a metabolic myopathy has not been reported. …

Abraham SC, DeNofrio D, Loh E, Minda JM, Tomaszewski JE, Pietra GG, Reynolds C (1998) Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy. Hum Pathol 29:876–882PubMedCrossRef

Arbustini E, Morbini P, Grasso M, Fasani R, Verga L, Bellini O, Dal Bello B, Campana C, Piccolo G, Febo O, Opasich C, Gavazzi A, Ferrans VJ (1998) Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol 31:645–653PubMedCrossRef

Arbustini E, Pasotti M, Pilotto A, Pellegrini C, Grasso M, Previtali S, Repetto A, Bellini O, Azan G, Scaffino M, Campana C, Piccolo G, Viganò M, Tavazzi L (2006) Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 8:477–483PubMedCrossRef

Berger PB, Duffy J, Reeder GS, Karon BL, Edwards WD (1994) Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc 69:162–165PubMed

Bertini E, Bosman C, Bevilacqua M, Ricci E, Gagliardi GM, Parisi F, Servidei S, Dionisi-Vici C, Ballerini L (1990) Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr 149:856–858PubMedCrossRef

Campos Y, Martín MA, Caballero C, Rubio JC, de la Cruz F, Tuñón T, Arenas J (2000) Single large-scale mitochondrial DNA deletion in a patient with encephalopathy, cardiomyopathy, and prominent intestinal pseudo-obstruction. Neuromuscul Disord 10: 56–58PubMedCrossRef

El-Menyar AA, Al-Suwaidi J, Gehani AA, Bener A (2004) Clinical and histologic studies of a Qatari family with myofibrillar myopathy. Saudi Med J 25:1723–1726PubMed

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA (2007) PROactive investigators. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). Diabetes Care 30:2773–2778PubMedCrossRef

Finsterer J, Stöllberger C, Avanzini M, Rauschka H (2006) Restrictive cardiomyopathy in dermatomyositis. Scand J Rheumatol 35:229–232PubMedCrossRef

10.

Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452PubMedCrossRef

11.

Ishiwata S, Nishiyama S, Seki A, Kojima S (1993) Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 57:928–933PubMed

12.

Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb-Peploe MM (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235PubMedCrossRef

13.

Ligi I, Fraisse A, Chabrol B, Paut O, Bourlon F, Métras D, Bonnet JL, Pellissier JF (2003) Restrictive cardiomyopathy due to myofibrillar myopathy. Arch Pediatr 10:432–435PubMedCrossRef

14.

Lincoff AM, Wolski K, Nicholls SJ, Nissen SE (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298:1180–1188PubMedCrossRef

15.

Pruszczyk P, Kostera-Pruszczyk A, Shatunov A, Goudeau B, Dramiñska A, Takeda K, Sambuughin N, Vicart P, Strelkov SV, Goldfarb LG, Kamiñska A (2007) Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. Int J Cardiol 117:244–253PubMedCrossRef

16.

Rottlaender D, Michels G, Erdmann E, Hoppe UC (2007) Therapy with glitazones—a risk for cardiovascular disease? Dtsch Med Wochenschr 132: 2629–2632PubMedCrossRef

17.

Sabatelli M, Bertini E, Ricci E, Salviati G, Magi S, Papacci M, Tonali P (1992) Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J Neurol Sci 109:1–10PubMedCrossRef

18.

Sanna T, Dello Russo A, Toniolo D, Vytopil M, Pelargonio G, De Martino G, Ricci E, Silvestri G, Giglio V, Messano L, Zachara E, Bellocci F (2003) Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J 24:2227–2236PubMedCrossRef

19.

Schwartz ML, Colan SD (2003) Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol 92:636–639PubMedCrossRef

20.

Stöllberger C, Finsterer J (2007) Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy. Clin Cardiol 30:375–380PubMedCrossRef

21.

Verny C, de Gennes C, Sébastien P, Lê Thi HD, Chapelon C, Piette JC, Chomette G, Godeau P (1992) Heart conduction disorders in long-term treatment with chloroquine. Two new cases. Presse Med 21:800–804PubMed

22.

Willemsen MA, van Oort AM, ter Laak HJ, Sengers RC, Gabreëls FJ (1997) Multicore myopathy with restrictive cardiomyopathy. Acta Paediatr 86: 1271–1274PubMedCrossRef

23.

Wöhrle J, Marx N, Koenig W, Hombach V, Kestler HA, Höher M, Nusser T (2008) Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease. Clin Res Cardiol 97:726–733PubMedCrossRef

Title: Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy
Authors: Univ. Prof. DDr. Josef Finsterer, MD, PhD
Claudia Stöllberger, MD
Publication date: 01-04-2009
Publisher: Steinkopff-Verlag
Published in: Clinical Research in Cardiology / Issue 4/2009
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-009-0757-y

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2009

Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure

Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients

Pseudoaneurysm of left ventricular following left ventricular apical venting

The year in Clinical Research in Cardiology

Biventricular repair despite hypoplastic tricuspid valve and right ventricle

Transcatheter closure of a ventricular septal defect adjacent to a post infarction aneurysm using an atrial septal defect occluder

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page